About this trial
Progress in the development of curative therapy for pediatric malignancies has resulted in increasing numbers of long-term childhood cancer survivors. This protocol is a means to provide continuing review of outcome and late toxicity for all patients actively being treated and previously treated for childhood cancer at St. Jude Children's Research Hospital.
Eligibility criteria
Qualifiers
All St Jude patients actively being followed or treated for childhood cancer
Disqualifiers
St. Jude consult only patients
St. Jude patients permanently discharged from care and follow-up Permanently discharged patients include patients who have electively transferred their oncologic care to another institution, those who are noncompliant with recommended follow-up or those leaving the institution against medical advice.
Patients referred to St. Jude for limited care on phase 1 protocol.
Trial design
Treatments tested in this trial
- Data Collection